SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-043175
Filing Date
2011-08-03
Accepted
2011-08-03 16:40:20
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-13819_110q.htm 10-Q 1063907
2 EX-31.1 a11-13819_1ex31d1.htm EX-31.1 12987
3 EX-31.2 a11-13819_1ex31d2.htm EX-31.2 13695
4 EX-32 a11-13819_1ex32.htm EX-32 11429
  Complete submission text file 0001104659-11-043175.txt   3753183

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT thrx-20110630.xml EX-101.INS 559722
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20110630.xsd EX-101.SCH 12656
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20110630_cal.xml EX-101.CAL 34240
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20110630_lab.xml EX-101.LAB 188440
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20110630_pre.xml EX-101.PRE 98721
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20110630_def.xml EX-101.DEF 65538
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 111007406
SIC: 2834 Pharmaceutical Preparations